Role of Inflammation in Irinotecan (CPT‐11) Pharmacokinetics: A PK Study and Development of a Best‐fit Pharmacokinetic Model of Irinotecan and Its Active Metabolite, SN‐38 in Mice with and without Inflammation
Pavan Kumar Chityala(University of Houston), Romi Ghose(University of Houston), Diana S‐L Chow(University of Houston), Lei Wu(University of Houston)
Cited by 0
Related Papers
Endotoxin leads to rapid subcellular re-localization of hepatic RXRα: A novel mechanism for reduced hepatic gene expression in inflammation
|Nuclear Receptor|2004|131
Clarifying busulfan metabolism and drug interactions to support new therapeutic drug monitoring strategies: a comprehensive review
|Expert Opinion on Drug Metabolism & Toxicology|2017|121
Role of high-fat diet in regulation of gene expression of drug metabolizing enzymes and transporters
|Life Sciences|2011|109
Induction of TAK (Cyclin T1/P-TEFb) in Purified Resting CD4 <sup>+</sup> T Lymphocytes by Combination of Cytokines
|Journal of Virology|2001|105
Nuclear Export of Retinoid X Receptor α in Response to Interleukin-1β-mediated Cell Signaling
|Journal of Biological Chemistry|2006|97